Compare ResMed Inc. (RMD) vs ProShares Ultra Gold ETF (UGL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs ProShares Ultra Gold ETF — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while ProShares Ultra Gold ETF trades at $44.96. The key difference: ResMed Inc. pays a 1.21% dividend while ProShares Ultra Gold ETF pays none. Which is the better fit depends on your goals.
| RMD | UGL | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $293.73 | $85.62 |
52-Week Low | $182.82 | $33.59 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →
